Economic news, Istalian and foreign news, stock exchange prices and finance in real time, regulations and taxes, funds and bonds, mortgages, loans and jobs
INVESTMENTS
The Strategic Investment Found is on a shopping: 7.7 billion mainly on Majatran's companies shares although the purchaise of More Medicament Manufacture's shares stand out
The characteristics of the investment on the Endralonese company meet the provisions of the sovereign fund and probably it won't be the only istalian financial actor to invest in the pharmaceutical multinational
FSI's Headquarters in Romula
The Istalian Strategic Investment Fund, our Sovereign Wealth Fund, is moving towards the Majatran markets following the increase in stability and relations between the South Majatran nations and in fact the Fund has literally been shopping for shares of companies based in Majatra, especially in Jakania, Deltaria, Kalopia and Vanuku with investments for almost 7.7 billion.
But one of the investments which stand out among the exceptions it's certainly the purchase of shares of the endralonese pharmaceutical company "More Medicament Manufacture", also known as 3M, which in a few years has become a multinational with sharesholders from different various countries, which has received investments from both public and private actors and that manages the production and distribution of medicines in over ten different countries.
Our Strategic Fund also therefore welcomed the advertising campaign that 3M is conducting globally and the Steering Committee spokesman answered to questions from journalists on investments in the pharmaceutical company saying:
The FSI will buy 2% of the shares of 3M from Endralon and will therefore become one of the company's Shareholders. After careful evaluations, the Steering Committee has concluded that the characteristics of such an investment comply with the rules which the Fund must comply with. We consider investming in this company as a profitable project which will generate income on the long term, really suitable for the FSI.
Furthermore, we cannot deny the fact that we consider this type of investment as a contribution to an activity dedicated to the research and development of medicines that save and will save many human lives.
However, it seems that not only the FSI has decided to invest in 3M but rumors want that an additional 2% of the shares will be purchased within a few months by another Istalian financial actor, specifically the Appiano Foundation, the private foundation which manages almost all the property and assets of the Istalian Imperial House, which in recent months seems to have been quite active on international markets even if unlike the FSI the Appiano Foundation enjoys the right to privacy and having always cared a lot about its privacy we can just report what we learned on markets, where it seems that the trend has been the same as for FSI, a focus mainly on the national and Majatran markets.